Belouski, Edward John,Ellison, Murielle Marie,Hamburger, Agnes Eva,Hecht, Randy Ira,Li, Yue-Sheng,Michaels, Mark Leo,Sun, Jeonghoon,Xu, Jing
申请号:
AU2016204968
公开号:
AU2016204968B2
申请日:
2016.07.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2016204968B220180301.pdf#####ABSTRACT OF THE DISCLOSURE The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such 5 nucleic acids, polypeptides, or pharmaceutical compositions.